Delivery Order SPE2DR25D1202-SPE2DR26F72TZ
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $3,279.40 to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Trelegy Ellipta 200-62.5-25, a combination inhalation powder medication used in respiratory disease management. This firm fixed-price, non-set-aside delivery order is scheduled for completion by September 19, 2025, with performance taking place at the vendor's corporate office in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $2,053.06 to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalation powder (60-count package). This is a firm fixed-price, non-set-aside contract with an ultimate completion date of December 8, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a $50,724.85 delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Trelegy Ellipta 100-62.5-25, a combination inhalation powder medication used in respiratory disease treatment. This firm fixed-price delivery order, which is not set-aside designated, represents a competitively awarded transaction under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to...
- The Defense Logistics Agency awarded a delivery order valued at $6,173.80 to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Trelegy Ellipta 200-62.5-25, a combination inhalation medication used in respiratory disease management. The contract is firm fixed price with no set-aside designation, indicating it was competitively awarded. Performance is to be completed by November 14, 2025, with the product delivered to Conshohocken, Pennsylvania, the vendor's corporate...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 6, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalers (60-count units) with a ceiling value of $12,948.24. This is a firm fixed price delivery order issued without a set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was selected to fulfill this medical supply requirement,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 8, 2025, for the supply of Trelegy Ellipta 200-62.5-25 inhalation powder in a 60-dose configuration, with a ceiling value of $13,819.64. This is a firm fixed-price delivery order with an ultimate completion date of December 9, 2025, and represents a non-set-aside competitive award. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Trelegy Ellipta 100-62.5-25 inhalers (60-count units) with a ceiling value of $2,837.16. This is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of December 10, 2025. This...
- The Defense Logistics Agency awarded a delivery order valued at $9,325.77 to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Trelegy Ellipta 200-62.5-25, a combination inhalation powder medication used in respiratory disease treatment. This non-set-aside, firm fixed-price delivery order is scheduled for completion by September 9, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,247.28 to AmerisourceBergen Drug Corp for Trelegy Ellipta 100-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. The contract, executed on June 20, 2025, with a completion date of June 23, 2025, is a firm fixed price delivery order with no set-aside designation, indicating competitive award. Performance will take place at AmerisourceBergen's corporate office location...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,365.23 to AmerisourceBergen Drug Corp for the supply of Trelegy Ellipta 100-62.5-25 inhalation powder in a 60-dose configuration. This non-competitive, firm fixed-price delivery order was awarded on September 19, 2025, with an ultimate completion date of September 22, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Trelegy Ellipta is a combination...
- SPE2DR25D1202Indefinite Delivery Contract
- SPE2DR25D1202-SPE2DR26F72TZDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $22,754.49 to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Trelegy Ellipta 200-62.5-25, a combination inhalation powder medication used in respiratory disease treatment. This firm fixed-price, non-set-aside delivery order is scheduled for completion by December 5, 2025, with performance being fulfilled from the contractor's facility in Conshohocken, Pennsylvania. The award represents a single transaction under the company's broader federal pharmaceutical supply framework with DLA. This delivery order is issued as a child contract under AmerisourceBergen Drug Corp's prime Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement and supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare systems worldwide. The company's IDC vehicle enables flexible fulfillment of pharmaceutical needs across multiple therapeutic domains for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems through competitive, firm fixed-price delivery orders.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.8k | 12/3/25 |